| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2011 | EP2344158A1 Use of isoQC inhibitors |
| 07/20/2011 | EP2344157A1 Novel inhibitors |
| 07/20/2011 | EP2344156A1 Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent |
| 07/20/2011 | EP2344155A2 Composition and method for treating dry eye syndrome |
| 07/20/2011 | EP2344154A1 Compositions that include anthocyanidins and methods of use |
| 07/20/2011 | EP2344153A1 Compound useful for treating cellulite |
| 07/20/2011 | EP2344152A2 Oral vaccines for producing mucosal immunity |
| 07/20/2011 | EP2344151A2 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 07/20/2011 | EP2344150A2 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 07/20/2011 | EP2344149A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis |
| 07/20/2011 | EP2344148A2 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 07/20/2011 | EP2344147A2 Nutritional support of the immune system during anti-cancer treatment |
| 07/20/2011 | EP2344146A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
| 07/20/2011 | EP2344145A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 07/20/2011 | EP2344144A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/20/2011 | EP2344143A1 Bioactive composition for the treatment of the hiv/aids, method for manufacturing and using the same |
| 07/20/2011 | EP2344142A1 Treatment of pervasive developmental disorders with redox-active therapeutics |
| 07/20/2011 | EP2344141A2 Compositions comrrising amlodipine and bisoprolol |
| 07/20/2011 | EP2344140A2 A method for the production of bioadhesive compact matrices |
| 07/20/2011 | EP2344139A1 Method for delivering a pharmaceutical composition to patient in need thereof |
| 07/20/2011 | EP2344137A1 Method for making cetirizine tablets |
| 07/20/2011 | EP2344136A1 Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| 07/20/2011 | EP2344133A2 A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same |
| 07/20/2011 | EP2344132A2 Liposomal systems comprising sphingomyelin |
| 07/20/2011 | EP2344130A2 Pharmaceutical topical compositions |
| 07/20/2011 | EP2344129A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 07/20/2011 | EP2344128A2 Ophthalmic administration of a composition including brimonidine as a mist |
| 07/20/2011 | EP2344126A1 Method for treatment of copd and other pulmonary diseases |
| 07/20/2011 | EP2344124A1 Implantable device for the delivery of risperidone and methods of use thereof |
| 07/20/2011 | EP2344123A2 Long term drug delivery devices with polyurethane-based polymers and their manufacture |
| 07/20/2011 | EP2344067A1 Cross-linked fatty acid-based biomaterials |
| 07/20/2011 | EP2343988A1 Nmp-containing extract, a method of its production and uses thereof |
| 07/20/2011 | EP2343980A1 Triazole antifungal agents |
| 07/20/2011 | EP2343979A1 Transdermal delivery |
| 07/20/2011 | EP2343978A1 Stabilized composition for treating psoriasis |
| 07/20/2011 | EP2343976A1 Methods of using sustained release aminopyridine compositions |
| 07/20/2011 | EP2343964A1 Transdermal delivery |
| 07/20/2011 | EP2343963A1 Transdermal delivery |
| 07/20/2011 | EP2252587B1 Piperidine sulfonamide derivatives |
| 07/20/2011 | EP2247595B1 Pyrrolopyrazine kinase inhibitors |
| 07/20/2011 | EP2190884B1 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivatives that can be used to functionalize chitosan. |
| 07/20/2011 | EP2168581A9 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 07/20/2011 | EP2139452B1 Polyaphron topical composition with vitamin d and corticosteroid |
| 07/20/2011 | EP2125788B9 Heterocyclic compounds, compositions comprising them and methods of their use |
| 07/20/2011 | EP2114935B1 Piperidine gpcr agonists |
| 07/20/2011 | EP2109449B1 Medicament for the treatment of endometriosis |
| 07/20/2011 | EP2097406B1 Hydantoin derivatives used as mmp inhibitors |
| 07/20/2011 | EP2094699B1 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 07/20/2011 | EP2091927B1 Thiazole and oxazole-substituted arylamides |
| 07/20/2011 | EP2089008B1 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 07/20/2011 | EP2049544B9 Purinone derivatives as hm74a agonists |
| 07/20/2011 | EP1994005B1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 07/20/2011 | EP1989191B1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 07/20/2011 | EP1987034B1 Spiro condensed piperidines as modulators of muscarinic receptors |
| 07/20/2011 | EP1858930B1 Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars |
| 07/20/2011 | EP1817282B1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 07/20/2011 | EP1786820B1 9-(1',5'-dimethyl-1'-vinyl-4'-hexenyl)-4-hydroxy-7h-furo[3,2-g][1]benzopyran-7-one as antibacterial agent |
| 07/20/2011 | EP1709018B1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 07/20/2011 | EP1697312B1 Hydroxamic acid esters and pharmaceutical use thereof |
| 07/20/2011 | EP1677767B1 Crystalline form of gamma-aminobutyric acid analog |
| 07/20/2011 | EP1605936B1 Aryl spirohydantoin cgrp receptor antagonists |
| 07/20/2011 | EP1496891B1 Methods for modulating phototoxicity |
| 07/20/2011 | EP1482920B2 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/20/2011 | EP1481966B1 Novel arylamidine derivative or salt thereof |
| 07/20/2011 | EP1377578B1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 07/20/2011 | EP1361884B1 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 07/20/2011 | EP1230237B2 Magnesium omeprazole |
| 07/20/2011 | EP1218007B1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/20/2011 | EP1214097B3 Nucleic acids encoding polyepitope polypeptides |
| 07/20/2011 | EP1018896B1 Nutritional composition for the treatment of pressure ulcers |
| 07/20/2011 | CN201899709U Astragalus polyose micropill |
| 07/20/2011 | CN1985875B Preparing process of Jade-screen total polyose |
| 07/20/2011 | CN1972924B Novel compounds |
| 07/20/2011 | CN1970001B Pharmaceutical composition comprising kurarinone, magnolia vine fruit and ginseng for treating hepatitis |
| 07/20/2011 | CN1950360B Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 07/20/2011 | CN1944448B Puerarin derivative and its medicinal use |
| 07/20/2011 | CN1939311B Ginseng sapogenin aglycone derivative biological preparation and its usage |
| 07/20/2011 | CN1938035B Therapeutic use of CPG oligodeoxynucleotide for skin disease |
| 07/20/2011 | CN1931214B Medicine composition of rhodiola root and puerarin |
| 07/20/2011 | CN1930137B Novel benzothiazepine and benzothiepine compounds |
| 07/20/2011 | CN1890228B Alpha-amino acid derivatives and use thereof as medicines |
| 07/20/2011 | CN1883469B An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof |
| 07/20/2011 | CN1882578B 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 07/20/2011 | CN1827632B Process for purifying zidovudine palmitate raw materials and preparations thereof |
| 07/20/2011 | CN1753656B Bioadhesive liquid composition which is substantially free of water |
| 07/20/2011 | CN1634007B Benzalkonium chloride contraceptive gel for quick eradication of multiple venereal disease pathogenic organism |
| 07/20/2011 | CN102131821A Glucocorticoids attached to nitrate esters via aromatic linker in position 21 and their use in ophthalmology |
| 07/20/2011 | CN102131820A Method for purification of natural cobalamins by adsorption on insoluble materials containing carboxylic groups |
| 07/20/2011 | CN102131816A Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 07/20/2011 | CN102131814A New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, process for preparing them, and application thereof in therapy as anticancer agents |
| 07/20/2011 | CN102131812A Pyrrolo[2,3-d]pyrimidine compounds |
| 07/20/2011 | CN102131811A Oxazolidinone derivative having fused ring |
| 07/20/2011 | CN102131810A Diketone fused azolopiperidines and azolopiperazines as anti-hiv agents |
| 07/20/2011 | CN102131809A Tri-cyclic pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131808A Pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131807A Pyrazolopyridine kinase inhibitors |
| 07/20/2011 | CN102131806A Triazolopyridine compounds useful as kinase inhibitors |
| 07/20/2011 | CN102131805A Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| 07/20/2011 | CN102131803A Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 07/20/2011 | CN102131802A New heterocyclic carboxamides for use as thrombin inhibitors |